Abstract: The invention relates to pharmaceutical combination preparations for use in the therapeutical and prophylactic treatment of bacterial and parasitic infections, especially malaria. The inventive preparations contain as the active substances 3-N-formyl-hydroxylaminopropyl phosphonic acid derivatives or 3-N-acetylhydroxylaminopropyl phosphonic acid derivatives combined with other pharmaceutical active agents.

Abstract: Use of phosphorous organic compounds of general formula (I) wherein B represents either an ether group of the formula (II) or a keto group of the formula (III) or is a 5 or 6 membered cyclic compound, and their use for preparing pharmaceutical compositions for the therapeutic and prophylactic treatment of infections in humans and animals due to viruses, bacteria, fungi, and parasites as well as their use as a fungicide, bactericide and herbicide in plants.

Abstract: The invention relates to the use of bisphosphonic acids of general formula (I) and derivatives thereof for the therapeutic and prophylactic treatment of infectious processes caused by viruses, bacteria, fungi or parasites in humans and animals, by deactivating the &ggr;&dgr;T cells.

Abstract: The invention relates to the use of compounds of the general formula (I) wherein Y is a C1-3-alkenylene group, wherein B is selected from the group, which consists of C1-26-alkenylene groups, wherein one C-atom is replaced by an oxygen atom and one C-atom is replaced by a sulphur atom or two C-atoms may be replaced by a S-heterocycle, and wherein X represents the organo phosphorous group. or the amino group for inhibition of the 1-deoxy-D-xylulose-5-phosphate-(DOXP)-metabolic pathway, use there of as a herbicide and for the preparation of a pharmaceutical preparation as well as a method for the therapeutic and prophylactic treatment of infections in humans and animals, caused by viruses, bacteria, fungi and parasites.

Abstract: The invention relates to organophosphorus compounds of general formula (I) wherein A corresponds to general formula (II), wherein one or more of the carbon atoms, selected from the group C3, C4, C5 and their respective substituents can be omitted, and at least one substituent of B1 to B10 is a C3-8 cycloalkyl (C0-9) alkyl group, wherein both the C3-8 cycloalkyl group and the C0-9 alkyl group can have one or more double bonds and one or two carbon atoms of the cycloalkyl group can be substituted by nitrogen, oxygen or sulfur atoms, and wherein both the cycloalkyl group and the alkyl group can be substituted by hydrogen, halogen amine, oxo groups with branched or unbranched C1-9 alkyl groups and C2-9 alkenyl groups, wherein the C1-9 alkyl groups and C2-9 alkenyl groups can be substituted by hydrogen, hydroxy, amine, halogen, and oxo groups.

Abstract: Use of phosphorous organic compounds of general formula (I) 1

Abstract: Use of phosphorous organic compounds of general formula (I) 1